These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15580507)

  • 1. Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model.
    Maataoui A; Qian J; Vossoughi D; Khan MF; Oppermann E; Bechstein WO; Vogl TJ
    Eur Radiol; 2005 Jan; 15(1):127-33. PubMed ID: 15580507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model.
    Qian J; Oppermann E; Tran A; Imlau U; Qian K; Vogl TJ
    World J Gastroenterol; 2016 Jun; 22(21):5042-9. PubMed ID: 27275096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma.
    Qian J; Truebenbach J; Graepler F; Pereira P; Huppert P; Eul T; Wiemann G; Claussen C
    World J Gastroenterol; 2003 Jan; 9(1):94-8. PubMed ID: 12508359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined transarterial chemoembolization and arterial administration of Bletilla striata in treatment of liver tumor in rats.
    Qian J; Vossoughi D; Woitaschek D; Oppermann E; Bechstein WO; Li WY; Feng GS; Vogl T
    World J Gastroenterol; 2003 Dec; 9(12):2676-80. PubMed ID: 14669311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol.
    Vogl TJ; Oppermann E; Qian J; Imlau U; Tran A; Hamidavi Y; Korkusuz H; Bechstein WO; Nour-Eldin NE; Gruber-Rouh T; Hammerstingl R; Naguib NN
    BMC Cancer; 2016 May; 16():325. PubMed ID: 27215551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-arterial interleukin-12 gene delivery combined with chemoembolization: anti-tumor effect in a rabbit hepatocellular carcinoma (HCC) model.
    Xia X; Li X; Feng G; Zheng C; Liang H; Zhou G
    Acta Radiol; 2013 Jul; 54(6):684-9. PubMed ID: 23507934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth characteristics and imaging properties of the morris hepatoma 3924A in ACI rats: a suitable model for transarterial chemoembolization.
    Trübenbach J; Graepler F; Pereira PL; Ruck P; Lauer U; Gregor M; Claussen CD; Huppert PE
    Cardiovasc Intervent Radiol; 2000; 23(3):211-7. PubMed ID: 10821896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver metastases in rats: chemoembolization combined with interstitial laser ablation for treatment.
    Maataoui A; Qian J; Mack MG; Khan MF; Oppermann E; Roozru M; Schmidt S; Bechstein WO; Vogl TJ
    Radiology; 2005 Nov; 237(2):479-84. PubMed ID: 16244257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats.
    Vogl TJ; Qian J; Tran A; Oppermann E; Naguib NN; Korkusuz H; Nour Eldin NE; Bechstein WO
    Diagn Interv Radiol; 2017; 23(2):150-155. PubMed ID: 28185998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor.
    Deng G; Zhao DL; Li GC; Yu H; Teng GJ
    Cardiovasc Intervent Radiol; 2011 Aug; 34(4):824-32. PubMed ID: 21671151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell apoptosis and regeneration of hepatocellular carcinoma after transarterial chemoembolization.
    Li Z; Hu DY; Chu Q; Wu JH; Gao C; Zhang YQ; Huang YR
    World J Gastroenterol; 2004 Jul; 10(13):1876-80. PubMed ID: 15222027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Animal experiment studies on the effectiveness of permanent occlusion of the hepatic artery in transarterial chemoembolization].
    Trübenbach J; Pereira PL; Graepler F; Huppert PE; Eul T; König CW; Duda SH; Claussen CD
    Rofo; 2000 Mar; 172(3):274-7. PubMed ID: 10778459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.
    Hyun D; Cho SK; Shin SW; Park KB; Park HS; Choo SW; Do YS; Choo IW; Lee MW; Rhim H; Lim HK
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):417-25. PubMed ID: 26246215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental study on transarterial administration of GRGDSP combined with transarterial chemoembolization in rats with hepatic carcinoma.
    Qian J; Yin J; Liang H; Wang Y; Feng G
    Cardiovasc Intervent Radiol; 2008; 31(2):377-82. PubMed ID: 18058171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR; Cristescu MM; Hinshaw A; Woo KM; Wells SA; Ziemlewicz TJ; Lubner MG; Dalvie PS; Louis Hinshaw J; Brace CL; Ozkan OS; Lee FT; Laeseke P
    Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of all trans-retinoic acid combined with transarterial chemoembolization on Walker-256 hepatoma in rats.
    Fang J; Zheng C; Tao H; Zhao H; Ren J; Feng G
    J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):113-8. PubMed ID: 20155467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant celecoxib and lanreotide following transarterial chemoembolisation for unresectable hepatocellular carcinoma: a randomized pilot study.
    Tong H; Wei B; Chen S; Xie YM; Zhang MG; Zhang LH; Huang ZY; Tang CW
    Oncotarget; 2017 Jul; 8(29):48303-48312. PubMed ID: 28430638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
    Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
    Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
    He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
    Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.